Article info
PDFVascular neurology
Quality of life among ischemic stroke patients eligible for endovascular treatment: analysis of the DEFUSE 3 trial
- Correspondence to Dr Ganesh Asaithambi, Neurosciences, Allina Health United Hospital, St. Paul, MI 55102, USA; ganesh785{at}gmail.com
Citation
Quality of life among ischemic stroke patients eligible for endovascular treatment: analysis of the DEFUSE 3 trial
Publication history
- Received May 20, 2020
- Revised July 7, 2020
- Accepted July 13, 2020
- First published August 4, 2020.
Online issue publication
January 10, 2022
Article Versions
- Previous version (9 January 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.